Aroa Biosurgery Ltd

  • IPO date:
  • Sector: Healthcare
  • GIC Group: Materials
  • Industry: Medical Devices
  • Company website

Company description

Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and sells medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.

Financial highlights

Market Capitalization$264.4499 million
P/E Ratio0
P/E Growth Ratio0
Book Value0.297
Dividend Per Share0
Earnings Per Share-0.0013
EBITDA-84
Profit Margin-0.0063
Operating Margin TTM-0.0491
Return on Assets TTM-0.017
Return on Equity TTM-0.3913
Revenue TTM63,360

Income statement highlights

All numbers are in thousands

Date Total Revenue Cost of Revenue Gross Profit Total Operating Expenses
2001-03-31
2002-03-31
2003-03-31
2004-03-31
2005-03-31
2006-03-31 753 87
2007-03-31 2
2008-03-31
2009-03-31 597
2010-03-31 11
2011-03-31
2012-03-31 1,255
2013-03-31
2014-03-31 875.488 770 875.488 2,408.254
2015-03-31 784.187 698 784.187 2,445.678
2016-03-31 680.748 205 680.748 1,987.762
2017-03-31 0 54 0 842.785
2018-03-31 11,100 5,630 5,470 889.605
2019-03-31 23,315 7,002 16,313 5,725.798
2020-03-31 25,076 6,339 18,737
2021-03-31 20,510.41954 6,259.06545 14,251.354080000001 28,700.08262
2022-03-31 36,880.751 8,715.49401 28,165.256989999998 39,216.46993
2023-03-31 59,309.182810000006 9,252.08275 50,057.10007 58,186.838899999995

Balance sheet highlights

All numbers are in thousands

Date Cash Total Assets Total Liabilities Short Term Debt Long Term Debt Common Stock
2001-03-31 10,000 13,851 12,043 29,754
2002-03-31 224 12,365 2,203 38,897
2003-03-31 383 12,121 2,350 38,897
2004-03-31 338 15,441 2,584 42,720
2005-03-31 1,700 19,600 4,373 46,114
2006-03-31 13,432 40,578 8,019 4,000 63,934
2007-03-31 9,514 88,532 58,226 32,870 75,317
2008-03-31 12,229 71,603 89,720 100,793
2009-03-31 2,076 83,083 105,731 5,877 132,059
2010-03-31 3,284 5,131 3,454 3,234 135,313
2011-03-31 4,037 8,075 3,319 1,499 140,292
2012-03-31 5,851 10,928 1,588 147,766
2013-03-31 3,772 9,357 355 148,388
2014-03-31 2,205 8,406 827 148,388
2015-03-31 1,506 7,510 586 149,130
2016-03-31 679.773 6,355.387 443.568 149,380.398
2017-03-31 800.131 6,515.135 234.689 150,443.876
2018-03-31 739.618 15,208 13,328 0 1,391 19,915
2019-03-31 1,910.897 39,460 27,460 0 431 28,889
2020-03-31 41,478.015009999996 82,535.82919 19,677.29356 1,029.5408 1,119 94,296.57795
2021-03-31 14,120.07711 73,124.94262 19,433.5812 9,655.74222 0 89,338.10704
2022-03-31 5,730.08644 104,705.82768 11,304.024539999999 547.44865 135,472.62756999998
2023-03-31 8,930.07582 109,071.42189 13,694.655060000001 523.26126 137,125.33932

Cash flow highlights

All numbers are in thousands

Date Net Income Total Cash Change in Cash Begin period cash End period cash Dividends
2001-03-31
2002-03-31
2003-03-31
2004-03-31
2005-03-31
2006-03-31
2007-03-31
2008-03-31
2009-03-31
2010-03-31 1,607
2011-03-31
2012-03-31
2013-03-31
2014-03-31 -1,466.017 -1,359.247 -1,566.411
2015-03-31 -1,616.409 -1,352.02 -699.159
2016-03-31 -1,292.92 -408.038 -397.384
2017-03-31 -722.652 -737.062 120.358
2018-03-31 -1,276 -3,036 2,808
2019-03-31 960 -7 579
2020-03-31 -5,958 1,660 -607 3,534.37988
2021-03-31 -19,209 -5,007 10,585.69724 3,534.37988 14,120.07711 18,180.48288
2022-03-31 -8,386 -11,522 -8,565.85184 14,295.938279999998 5,730.08644
2023-03-31 -370.68239 -3,772 3,159.22494 5,770.85088 8,930.07582